Similar articles for PMID: 14684304

Year	Number of Results
1960	1
1967	1
1993	1
1996	1
1997	3
1998	4
1999	4
2000	8
2001	10
2002	8
2003	5
2004	15
2005	11
2006	11
2007	8
2008	8
2009	4
2010	6
2012	1
2013	2
2014	1
2015	3
2016	2
2017	1
2018	4
2019	2
2020	1
2021	1
2022	2
2023	2
2024	0

1

(4-Piperidinylphenyl)aminoethyl amides as a novel class of non-covalent cathepsin K inhibitors.

Kim TS, Hague AB, Lee TI, Lian B, Tegley CM, Wang X, Burgess TL, Qian YX, Ross S, Tagari P, Lin CH, Mayeda C, Dao J, Jordan S, Mohr C, Cheetham J, Viswanadhan V, Tasker AS. Kim TS, et al. Bioorg Med Chem Lett. 2004 Jan 5;14(1):87-90. doi: 10.1016/j.bmcl.2003.10.009. Bioorg Med Chem Lett. 2004. PMID: 14684304

2

Non-covalent cathepsin K inhibitors for the treatment of osteoporosis.

Kim TS, Tasker AS. Kim TS, et al. Curr Top Med Chem. 2006;6(4):355-60. doi: 10.2174/156802606776287036. Curr Top Med Chem. 2006. PMID: 16611147 Review.

3

Arylaminoethyl amides as novel non-covalent cathepsin K inhibitors.

Altmann E, Renaud J, Green J, Farley D, Cutting B, Jahnke W. Altmann E, et al. J Med Chem. 2002 Jun 6;45(12):2352-4. doi: 10.1021/jm010801s. J Med Chem. 2002. PMID: 12036343

4

Arylaminoethyl amides as inhibitors of the cysteine protease cathepsin K-investigating P1' substituents.

Altmann E, Green J, Tintelnot-Blomley M. Altmann E, et al. Bioorg Med Chem Lett. 2003 Jun 16;13(12):1997-2001. doi: 10.1016/s0960-894x(03)00344-5. Bioorg Med Chem Lett. 2003. PMID: 12781182

5

Primary amides as selective inhibitors of cathepsin K.

Léger S, Bayly CI, Black WC, Desmarais S, Falgueyret JP, Massé F, Percival MD, Truchon JF. Léger S, et al. Bioorg Med Chem Lett. 2007 Aug 1;17(15):4328-32. doi: 10.1016/j.bmcl.2007.05.024. Epub 2007 May 16. Bioorg Med Chem Lett. 2007. PMID: 17544269

6

Arylaminoethyl amides as noncovalent inhibitors of cathepsin S. Part 2: Optimization of P1 and N-aryl.

Alper PB, Liu H, Chatterjee AK, Nguyen KT, Tully DC, Tumanut C, Li J, Harris JL, Tuntland T, Chang J, Gordon P, Hollenbeck T, Karanewsky DS. Alper PB, et al. Bioorg Med Chem Lett. 2006 Mar 15;16(6):1486-90. doi: 10.1016/j.bmcl.2005.12.056. Epub 2006 Jan 18. Bioorg Med Chem Lett. 2006. PMID: 16412634

7

A potent small molecule, nonpeptide inhibitor of cathepsin K (SB 331750) prevents bone matrix resorption in the ovariectomized rat.

Lark MW, Stroup GB, James IE, Dodds RA, Hwang SM, Blake SM, Lechowska BA, Hoffman SJ, Smith BR, Kapadia R, Liang X, Erhard K, Ru Y, Dong X, Marquis RW, Veber D, Gowen M. Lark MW, et al. Bone. 2002 May;30(5):746-53. doi: 10.1016/s8756-3282(02)00675-0. Bone. 2002. PMID: 11996914

8

Beta-substituted cyclohexanecarboxamide cathepsin K inhibitors: modification of the 1,2-disubstituted aromatic core.

Robichaud J, Bayly CI, Black WC, Desmarais S, Léger S, Massé F, McKay DJ, Oballa RM, Pâquet J, Percival MD, Truchon JF, Wesolowski G, Crane SN. Robichaud J, et al. Bioorg Med Chem Lett. 2007 Jun 1;17(11):3146-51. doi: 10.1016/j.bmcl.2007.03.028. Epub 2007 Mar 15. Bioorg Med Chem Lett. 2007. PMID: 17408953

9

6. Cathepsin K inhibitors: their potential as anti-osteoporosis agents.

Deaton DN, Kumar S. Deaton DN, et al. Prog Med Chem. 2004;42:245-375. doi: 10.1016/S0079-6468(04)42006-2. Prog Med Chem. 2004. PMID: 15003723 Review. No abstract available.

10

Novel, nonpeptidic cyanamides as potent and reversible inhibitors of human cathepsins K and L.

Falgueyret JP, Oballa RM, Okamoto O, Wesolowski G, Aubin Y, Rydzewski RM, Prasit P, Riendeau D, Rodan SB, Percival MD. Falgueyret JP, et al. J Med Chem. 2001 Jan 4;44(1):94-104. doi: 10.1021/jm0003440. J Med Chem. 2001. PMID: 11141092

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

126 results

Results by year